Compositions and methods to modulate an immune response to an immunogenic therapeutic agent

Details for Australian Patent Application No. 2004287431 (hide)

Owner Amgen Inc.

Inventors Feige, Ulrich; Khare, Sanjay D.

Agent Spruson & Ferguson

Pub. Number AU-B-2004287431

PCT Pub. Number WO2005/044188

Priority 60/515,199 27.10.03 US

Filing date 26 October 2004

Wipo publication date 19 May 2005

Acceptance publication date 11 March 2010

International Classifications

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

Event Publications

25 May 2006 PCT application entered the National Phase

  PCT publication WO2005/044188 Priority application(s): WO2005/044188

11 March 2010 Application Accepted

  Published as AU-B-2004287431

8 July 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004287434-Methods of lowering lipid levels in a mammal

2004287430-Safety spinal catheter